A detailed history of Swiss National Bank transactions in Mannkind Corp stock. As of the latest transaction made, Swiss National Bank holds 531,500 shares of MNKD stock, worth $3.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
531,500
Previous 528,900 0.49%
Holding current value
$3.51 Million
Previous $2.76 Million 20.91%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$5.01 - $6.7 $13,026 - $17,420
2,600 Added 0.49%
531,500 $3.34 Million
Q4 2023

Feb 06, 2024

SELL
$3.34 - $4.29 $174,014 - $223,509
-52,100 Reduced 8.97%
528,900 $1.93 Million
Q3 2023

Nov 08, 2023

BUY
$3.91 - $5.45 $22,287 - $31,065
5,700 Added 0.99%
581,000 $2.4 Million
Q2 2023

Aug 09, 2023

BUY
$3.72 - $4.79 $132,432 - $170,524
35,600 Added 6.6%
575,300 $2.34 Million
Q1 2023

May 10, 2023

SELL
$3.95 - $5.63 $199,870 - $284,878
-50,600 Reduced 8.57%
539,700 $2.21 Million
Q4 2022

Feb 08, 2023

BUY
$3.02 - $5.37 $64,326 - $114,381
21,300 Added 3.74%
590,300 $3.11 Million
Q3 2022

Nov 09, 2022

BUY
$2.99 - $4.35 $13,754 - $20,010
4,600 Added 0.82%
569,000 $1.76 Million
Q1 2022

May 09, 2022

BUY
$2.62 - $4.45 $112,136 - $190,460
42,800 Added 8.21%
564,400 $2.08 Million
Q2 2021

Aug 06, 2021

BUY
$3.61 - $5.45 $1.88 Million - $2.84 Million
521,600 New
521,600 $2.84 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.7B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.